You are here: Industry Insights > cardiovascular

News List

Nonfasting Lipid Levels Adequate for Assessing Cardiovascular Risk drugs
June 03, 2019
Nonfasting Lipid Levels Adequate for Assessing Cardiovascular Risk.
Forget Fasting Before That Cholesterol Test drugs
May 31, 2019
For folks who hate to fast before getting a blood test to check their cholesterol levels, a new study delivers some good news.
AHA News: Drummer's Death Inspires Grief-Stricken Bandmates to Rethink Rock 'n' Roll Lifestyle drugs
May 20, 2019
Drummer's Death Inspires Grief-Stricken Bandmates to Rethink Rock 'n' Roll Lifestyle.
Pooled Analyses of the Roxadustat Global Phase III Programme Confirmed Cardiovascular Safety drugs
May 20, 2019
Pooled Analyses of the Roxadustat Global Phase III Programme Confirmed Cardiovascular Safety.
Cardio-Oncology Services Growing in Number and Demand drugs
May 06, 2019
Cardio-Oncology Services Growing in Number and Demand...
SomaLogic & Janssen Enter Agreement contractpharma
April 15, 2019
SomaLogic to analyze ~5000 proteins in each of at least 15,000 clinical samples from Janssen to identify & validate protein biomarkers for use to treat diseases...
FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture worldpharmanews
April 12, 2019
FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture.
Benzodiazepines could decrease mortality in congestive heart failure europeanpharmaceuticalreview
April 10, 2019
Researchers have suggested that benzodiazepines should be the first course of treatment for those with cardiovascular disease and anxiety…
Fresh off new Farxiga data, AstraZeneca diabetes push points up cardiovascular, renal risks fiercepharma
April 02, 2019
AstraZeneca has been pumping dollars into studying its Type 2 diabetes drugs and their ability to stave off complications like heart disease and kidney problems……
Diabetes drug effective against heart failure in wide spectrum of patients worldpharmanews
March 19, 2019
The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction...

Previous page 1 2 3 4 5 6 7 8 9 10 Next page